Nouscom Series D: €120M

Oct 19, 2026Public sources — Collected from public sources, not yet cross-checked.

Nouscom raised €120 million (about $135.04 million) in a series d round led by M Ventures and Revelation Partners, announced Oct. 19.

Facts

Company: Nouscom
Amount: €120 million (about $135.04 million)
Currency: EUR
Stage: Series D
Announced: Oct 19, 2026
Instrument: Equity
FX rate: 1 EUR = 1.1253 USD on Oct 16, 2026

Investors

Led by: M Ventures Revelation Partners
Participants: Angelini Ventures EIB Neva SGR 5AM Ventures Andera Partners Bpifrance CDP Venture Capital EQT Life Sciences Indaco Venture Partners Panakes Partners Versant Ventures XGEN Ventures

Use of funds

Advance NOUS-209 through a single, global, registration-enabling clinical trial for cancer interception in Lynch Syndrome carriers.

As stated by the company.

Sources

1.Switzerland’s Nouscom bags €120 million to bring innovative cancer immunotherapy closer to clinical trials — EU-Startups, Oct 19, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Oct 19, 2026